Eric Loumeau - Jun 8, 2022 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
COO, General Counsel
Signature
/s/ Eric Loumeau
Stock symbol
ANAB
Transactions as of
Jun 8, 2022
Transactions value $
-$24,950
Form type
4
Date filed
6/10/2022, 05:22 PM
Previous filing
May 20, 2022
Next filing
Jun 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Options Exercise $35.1K +2.5K +478.01% $14.02 3.02K Jun 8, 2022 Direct
transaction ANAB Common Stock Sale -$60K -2.5K -82.7% $24.00 523 Jun 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Employee Stock Option (Right to Buy) Options Exercise $0 -2.5K -2.92% $0.00 83K Jun 8, 2022 Common Stock 2.5K $14.02 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2 The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F3 In addition to the remaining options to purchase 83,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 215,000 shares of common stock, which options vest according to their terms.